BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 8594208)

  • 41. Platelet activating factor increases ciliary activity in the hamster oviduct through epithelial production of prostaglandin E2.
    Hermoso M; Barrera N; Morales B; Pérez S; Villalón M
    Pflugers Arch; 2001 Jun; 442(3):336-45. PubMed ID: 11484763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ozone stimulates release of platelet activating factor and activates phospholipases in guinea pig tracheal epithelial cells in primary culture.
    Wright DT; Adler KB; Akley NJ; Dailey LA; Friedman M
    Toxicol Appl Pharmacol; 1994 Jul; 127(1):27-36. PubMed ID: 8048050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of the NMDA receptor/nitric oxide signal pathway in platelet-activating factor-induced neurotoxicity.
    Xu Y; Tao YX
    Neuroreport; 2004 Feb; 15(2):263-6. PubMed ID: 15076749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arachidonate metabolites, platelet-activating factor, and the mobilization of protein kinase C in human polymorphonuclear neutrophils.
    O'Flaherty JT; Nishihira J
    J Immunol; 1987 Mar; 138(6):1889-95. PubMed ID: 3029224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia.
    Muralikrishna Adibhatla R; Hatcher JF
    Free Radic Biol Med; 2006 Feb; 40(3):376-87. PubMed ID: 16443152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene.
    Bazan NG; Fletcher BS; Herschman HR; Mukherjee PK
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5252-6. PubMed ID: 8202477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Signaling and interplay mediated by phospholipases A2, C, and D in LA-N-1 cell nuclei.
    Farooqui AA; Horrocks LA
    Reprod Nutr Dev; 2005; 45(5):613-31. PubMed ID: 16188211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The onset of brain injury and neurodegeneration triggers the synthesis of docosanoid neuroprotective signaling.
    Bazan NG
    Cell Mol Neurobiol; 2006; 26(4-6):901-13. PubMed ID: 16897369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Respective roles of the 14 kDa and 85 kDa phospholipase A2 enzymes in human monocyte eicosanoid formation.
    Marshall LA; Bolognese B; Roshak A
    Adv Exp Med Biol; 1999; 469():215-9. PubMed ID: 10667333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet-activating factor preferentially stimulates the phospholipase A2/cyclooxygenase cascade in the rabbit cornea.
    Hurst JS; Bazan HE
    Curr Eye Res; 1995 Sep; 14(9):769-75. PubMed ID: 8529415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet-activating factor is a downstream messenger of kainate-induced activation of mitogen-activated protein kinases in primary hippocampal neurons.
    DeCoster MA; Mukherjee PK; Davis RJ; Bazan NG
    J Neurosci Res; 1998 Aug; 53(3):297-303. PubMed ID: 9698157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Arachidonic acid metabolism and cerebral blood flow in the normal, ischemic, and reperfused gerbil brain. Inhibition of ischemia-reperfusion-induced cerebral injury by a platelet-activating factor antagonist (BN 52021).
    Panetta T; Marcheselli VL; Braquet P; Bazan NG
    Ann N Y Acad Sci; 1989; 559():340-51. PubMed ID: 2774404
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Role of excitatory amino acids in neuropathology].
    Wikinski SI; Acosta GB
    Medicina (B Aires); 1995; 55(4):355-65. PubMed ID: 8728878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist.
    Yue TL; Gleason MM; Gu JL; Lysko PG; Hallenbeck J; Feuerstein G
    J Pharmacol Exp Ther; 1991 Apr; 257(1):374-81. PubMed ID: 1850473
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet activating factor and endotoxin increase the enzyme activity and gene expression of type II phospholipase A2 in the rat intestine. Role of polymorphonuclear leukocytes.
    Tan XD; Wang H; Gonzalez-Crussi FX; Chang H; Gonzalez-Crussi F; Hsueh W
    J Immunol; 1996 Apr; 156(8):2985-90. PubMed ID: 8609420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain phospholipases A2: a perspective on the history.
    Farooqui AA; Horrocks LA
    Prostaglandins Leukot Essent Fatty Acids; 2004 Sep; 71(3):161-9. PubMed ID: 15253885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phospholipase A2.
    Murakami M; Kudo I
    J Biochem; 2002 Mar; 131(3):285-92. PubMed ID: 11872155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glutamate signalling and secretory phospholipase A2 modulate the release of arachidonic acid from neuronal membranes.
    Rodriguez De Turco EB; Jackson FR; DeCoster MA; Kolko M; Bazan NG
    J Neurosci Res; 2002 Jun; 68(5):558-67. PubMed ID: 12111845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG.
    Bartemes KR; McKinney S; Gleich GJ; Kita H
    J Immunol; 1999 Mar; 162(5):2982-9. PubMed ID: 10072549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New insights into the retinal circulation: inflammatory lipid mediators in ischemic retinopathy.
    Hardy P; Beauchamp M; Sennlaub F; Gobeil F; Tremblay L; Mwaikambo B; Lachapelle P; Chemtob S
    Prostaglandins Leukot Essent Fatty Acids; 2005 May; 72(5):301-25. PubMed ID: 15850712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.